KOPRAN.NS Live signals | Maximize Profits with Getagraph.com

Live Chart Being Loaded With Signals

Commentary (3 May 2024 @ 01:11):

Kopran Limited, an integrated pharmaceutical company, manufactures and sells active pharmaceutical ingredients and finished dosage forms in India and internationally...

Stats
Today's Volume	87 229.00
Average Volume	536 861
Market Cap	12.12B
EPS	INR0 ( 2024-02-06 )
Next earnings date	( INR0 ) 2024-05-23
Last Dividend	INR3.00 ( 2023-09-07 )
Next Dividend	INR0 ( N/A )
P/E	30.07
ATR14	INR0.371 (0.15%)

Volume Correlation

Long: -0.19 (neutral)

Short: -0.16 (neutral)

Signal:(45.555) Neutral

Kopran Limited Correlation

10 Most Positive Correlations

10 Most Negative Correlations

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Kopran Limited Correlation - Currency/Commodity

0.41
( neutral )

0.14
( neutral )

-0.50
( weak negative )

0.01
( neutral )

-0.25
( neutral )

Kopran Limited Financials

Annual	2022
Revenue:	INR5.51B
Gross Profit:	INR1.92B (34.92 %)
EPS:	INR5.65

FY	2022
Revenue:	INR5.51B
Gross Profit:	INR1.92B (34.92 %)
EPS:	INR5.65

FY	2022
Revenue:	INR4.74B
Gross Profit:	INR1.90B (40.10 %)
EPS:	INR13.77

FY	2021
Revenue:	INR4.81B
Gross Profit:	INR1.67B (34.72 %)
EPS:	INR14.24

Financial Reports:

No articles found.

Kopran Limited Dividends

(Q3/22)	(Q4/22)	(Q1/23)	(Q2/23)	(Q3/23)	(Q4/23)	(Q1/24)	(Q2/24)	(Q3/24)	(Q4/24)
INR3.00 (N/A)	INR0 (N/A)	INR0 (N/A)	INR0 (N/A)	INR3.00 (N/A)	INR0 (N/A)	INR0 (N/A)	INR0 (N/A)	INR0 (N/A)	INR0 (N/A)

Kopran Limited Dividend Information - Dividend Junior

Dividend Sustainability Score: 3.83 - low (27.53%) | Divividend Growth Potential Score: 2.61 - Decrease likely (47.70%)

Very Unsafe

High risk of being cut

Unsafe

Heightened risk of being cut

Borderline

Moderate risk of being cut

Safe

Unlikely to be cut

Very Safe

Very unlikely to be cut

Information

First Dividend	INR1.500	2020-11-05
Last Dividend	INR3.00	2023-09-07
Next Dividend	INR0	N/A
Payout Date	0000-00-00
Next Payout Date	N/A
# dividends	4	--
Total Paid Out	INR9.00	--
Avg. Dividend % Per Year	1.18%	--
Score	1.98	--
Div. Sustainability Score	3.83
Div.Growth Potential Score	2.61
Div. Directional Score	3.22	--

Next Divdend (Est)
(2024-05-20)

INR3.25 Estimate 3.08 %

Dividend Stability

0.25 Very Poor

Dividend Score

1.98

Pay Frequency

Annually

Yearly Payout

Year	Amount	Yield
2020	INR1.500	4.82%
2021	INR1.500	1.08%
2022	INR3.00	0.91%
2023	INR3.00	2.01%
2024	INR0	0.00%

Dividend Commentary

The company's low Dividend Sustainability Score (DSS) highlights potential challenges in upholding its current dividend levels. Unfortunately, its low Dividend Growth Potential Score (DGPS) suggests limited prospects for dividend growth. In conclusion, a more vigilant stance is recommended given the company's tentative dividend landscape.

Top 10 dividend Companies for NSE

Symbol	Title	Last dividend	Frequency	Years Dividend	Yearly Dividend
TASTYBITE.NS	Dividend Junior	2023-07-14	Annually	8	0.01%
NH.NS	Dividend Junior	2023-07-06	Sporadic	6	0.14%
IMPAL.NS	Dividend Junior	2023-07-20	Annually	19	1.79%
CHEVIOT.NS	Dividend Junior	2023-08-03	Annually	3	1.62%
SALASAR.NS	Dividend Junior	2023-09-15	Annually	8	1.41%
LUPIN.NS	Dividend Junior	2023-07-14	Annually	23	0.37%
GIPCL.NS	Dividend Junior	2023-09-08	Annually	21	2.50%
ASHIANA.NS	Dividend Junior	2023-09-21	Annually	14	0.37%
TIMETECHNO.NS	Dividend Junior	2023-09-18	Annually	17	0.93%
PARADEEP.NS	No Dividend Player	2023-09-18	Insufficient data to determine frequency	2	0.28%

Dividend Sustainability Score (DSS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
netProfitMarginTTM	0.0697	1.500	8.61	10.00	[0 - 0.5]
returnOnAssetsTTM	0	1.200	0	0	[0 - 0.3]
returnOnEquityTTM	0.0917	1.500	-0.0923	-0.139	[0.1 - 1]
payoutRatioTTM	0	-1.000	0	0	[0 - 1]
currentRatioTTM	0	0.800	-5.00	-4.00	[1 - 3]
quickRatioTTM	0	0.800	-4.71	-3.76	[0.8 - 2.5]
cashRatioTTM	0	1.500	-1.111	-1.667	[0.2 - 2]
debtRatioTTM	0	-1.500	0	0	[0 - 0.6]
interestCoverageTTM	7.54	1.000	8.32	8.32	[3 - 30]
operatingCashFlowPerShareTTM	8.79	2.00	7.07	10.00	[0 - 30]
freeCashFlowPerShareTTM	3.38	2.00	8.31	10.00	[0 - 20]
debtEquityRatioTTM	0	-1.500	0	0	[0 - 2.5]
grossProfitMarginTTM	0.356	1.000	7.40	7.40	[0.2 - 0.8]
operatingProfitMarginTTM	0.101	1.000	9.97	9.97	[0.1 - 0.6]
cashFlowToDebtRatioTTM	0	1.000	-1.111	-1.111	[0.2 - 2]
assetTurnoverTTM	0	0.800	-3.33	-2.67	[0.5 - 2]
Total Score				3.83

Dividend Growth Score (DGS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
peRatioTTM	31.02	1.000	6.97	0	[1 - 100]
returnOnEquityTTM	0.0917	2.50	-0.0594	-0.139	[0.1 - 1.5]
freeCashFlowPerShareTTM	3.38	2.00	8.87	10.00	[0 - 30]
dividendYielPercentageTTM	1.155	1.500	10.00	0	[0 - 0.4]
operatingCashFlowPerShareTTM	8.79	2.00	7.07	10.00	[0 - 30]
payoutRatioTTM	0	1.500	0	0	[0 - 1]
pegRatioTTM	-9.40	1.500	-10.00	0	[0.5 - 2]
operatingCashFlowSalesRatioTTM	0.0732	1.000	-0.670	0	[0.1 - 0.5]
Total Score				2.61

Kopran Limited

Kopran Limited, an integrated pharmaceutical company, manufactures and sells active pharmaceutical ingredients and finished dosage forms in India and internationally. The company offers its products in various dosage forms, including tablets, capsules, dry powder, suspension, and injectables. It also provides active pharmaceutical ingredients in the categories of macrolide, antibacterial, anticonvulsant, anti-hypertensive, anti-helmentics, anti-histamine, anti-acne, anti-infective, urological, anti-thrombotic, antidiabetic, pain management, gastroenterology, and cardiovascular. The company was incorporated in 1958 and is headquartered in Mumbai, India.